基于1H NMR的代谢组学方法研究葛根芩连汤对高果糖诱导胰岛素抵抗大鼠粪便代谢组的影响

doi:10.11938/cjmr20182643

摘要/Abstract

摘要： 研究表明过量高果糖摄入可诱导胰岛素抵抗（IR）.葛根芩连汤（GQD）是临床常用的治疗2型糖尿病和胰岛素抵抗的中药之一，但其对果糖诱导的胰岛素抵抗的肠道菌群影响的相关研究甚少.本文采用基于核磁共振氢谱（¹H NMR）的代谢组学方法研究了GQD对高果糖诱导的胰岛素抵抗大鼠粪便代谢组的调控作用.通过连续8周给予大鼠10%果糖水喂养，成功建立胰岛素抵抗大鼠模型，GQD治疗组在果糖水喂养第5周至第8周同时给予GQD（18.2g/kg/day）灌胃.结果表明：与正常对照组相比，胰岛素抵抗模型组大鼠的饮水量、饮食量、体重和IR指数明显增加，空腹血糖值在第8周明显上升.在第8周末期，GQD治疗组的IR指数较胰岛素抵抗模型组显著降低，并且代谢紊乱得到改善：与胰岛素抵抗模型组相比，GQD治疗组胰岛素抵抗中丙酸、乙酸、琥珀酸、牛磺酸和甘油水平增加；而正丁酸、丙氨酸和谷氨酸的含量降低.这一结果表明GQD能够改善胰岛素抵抗所引起的大鼠氨基酸代谢、脂肪酸氧化和肠道微生物代谢等代谢紊乱状态.

关键词: 胰岛素抵抗, 葛根芩连汤, 代谢组学, 核磁共振氢谱, 高果糖

Abstract: Gegen Qinlian Decoction (GQD) is a commonly used traditional Chinese medicine formula for treating type 2 diabetes mellitus and insulin resistance (IR). The effects of GQD treatment on intestinal flora and its metabolism, however, are yet to be understood. In this study, the effects of GQD treatment on the fecal metabonome of high fructose-induced IR rats were investigated with a ¹H NMR-based approach. The IR model was established by feeding the rats with 10% fructose solution for 8 consecutive weeks. The animals in the GQD treatment group were gavaged with GQD daily (18.2 g/kg/day) from the 5th to 8th week. Compared with control group, The IR rats showed significantly increases in water/food intakes, body weight and IR index at the ends of the 4th and 8th week. The fasted plasma glucose (FPG) level of the IR rats increased by the end of the 8th week. The GQD treatment lowered the IR index and normalized fecal metabonome by increasing the levels of propionate, acetate, succinate, taurine and glycerol, while decreasing the levels of n-butyrate, alanine and glutamate. These results indicated that the GQD treatment induced positive changes in amino acid metabolism, fatty acid oxidation and gut microbiota metabolism in the IR rats.

Key words: insulin resistance, Gegen Qinlian Decoction, metabonomics, ¹H NMR, high fructose

中图分类号:

O482.53

汪双红, 曾培, 潘思娜, 王佳, 王淑美, 杨永霞. 基于¹H NMR的代谢组学方法研究葛根芩连汤对高果糖诱导胰岛素抵抗大鼠粪便代谢组的影响[J]. 波谱学杂志, 2019, 36(2): 182-194.

WANG Shuang-hong, ZENG Pei, PAN Si-na, WANG Jia, WANG Shu-mei, YANG Yong-xia. Effects of Gegen Qinlian Decoction on the Fecal Metabonome of High Fructose-Induced Insulin Resistance Rats Studied by ¹H NMR Spectroscopy[J]. Chinese Journal of Magnetic Resonance, 2019, 36(2): 182-194.

参考文献

[1] ISEZUO S A. The metabolic syndrome:Review of current concepts[J]. Niger Postgrad Med J, 2006, 13(3):247-255.
[2] ASTRUP A, DYERBERG J, SELLECK M, et al. Nutrition transition and its relationship to the development of obesity and related chronic diseases[J]. Obes Rev, 2008, 9(suppl 1):48-52.
[3] MISRA A, KHURANA L. Obesity and the metabolic syndrome in developing countries[J]. J Clin Endocrinol Metab, 2008, 93(Suppl 1):S9-S30.
[4] GAO Y, SONG G Y, ZHOU Y, et al. Vasodilation reduction and insulin resistance in rats induced by high sucrose, high saturated fatty acid and high unsaturated fatty acid diets[J]. Basic & Clinical Medicine, 2006, 26(3):275-279. 高宇, 宋光耀, 周宇, 等. 高糖、高脂饮食诱导大鼠胰岛素抵抗和血管舒张功能减弱[J]. 基础医学与临床, 2006, 26(3):275-279.
[5] HWANG I S, HO H, HOFFMAN B B, et al. Fructose-induced insulin resistance and hypertension in rats[J]. Hypertension, 1987, 10(5):512-516.
[6] DEKKER M J, SU Q Z, BAKER C, et al. Fructose:a highly lipogenic nutrient implicated in insulin resistance, hepatic steatosis, and the metabolic syndrome[J]. Am J Physiol Endocrinol Metab, 2010, 299(5):E685-E694.
[7] YANG Y X, WANG L L, WANG S M, et al. An integrated metabonomic approach to studing metabolic profiles in rat models with insulin resistance induced by high fructose[J]. Mol Biosyst, 2015, 10(7):1803-1811.
[8] SI D H, CHEN L Y. Drug treatment of insulin resistance[J]. China Pharmacist, 2005, 8(7):70-72. 史道华, 陈鹭颖. 胰岛素抵抗的药物治疗[J]. 中国药师, 2005, 8(7):70-72.
[9] LIU H Q, ZHONG L J, JI B P, et al. Drug treatment of insulin resistance[J]. China Pharmaceuticals, 2005, 14(1):77-78. 刘洪庆, 仲丽军, 纪宝平, 等. 胰岛素抵抗的药物治疗[J]. 中国药业, 2005, 14(1):77-78.
[10] 王琳琳. 黄连解毒汤改善胰岛素抵抗的代谢组学研究[D]. 广州:广东药学院, 2015.
[11] ZHU Z Z, XIONG M Q, LIN A Z, et al. Effect of Sanhuang Jiangtang (三黄降糖) recipe on insulin peripheral resistance in type Ⅱ diabetes mellitus[J]. Chinese Journal of Integrated Traditional and Western Medicine, 1999, 5(1):36-40.
[12] ZOU W J, BAI H Y, GAO X P. The influence of P thomsonii Benth on insulin resistance induced by dexamethasone[J]. Chinese Pharmacological Bulletin, 2004, 20(6):715-716. 邹文俊, 白红艳, 高小平. 中药葛根改善胰岛素抵抗作用的实验研究[J]. 中国药理学通报, 2004, 20(6):715-716.
[13] JIN L, AN W C, AN W D. Treatment of 120 cases of diabetes with Gegen Qinlian Decoction[J]. Journal of Changchun University of Traditional Chinese Medicine, 2012, 28(2):315. 金莉, 安文灿, 安文铎. 葛根芩连汤治疗糖尿病120例[J]. 长春中医药大学学报, 2012, 28(2):315.
[14] LI Y M, FAN X M, WANG Y M, et al. Therapeutic effects of Gegen Qinlian decoction and its mechanism of action on type 2 diabetic rats[J]. Acta Pharmaceutica Sinica, 2013, 48(9):1415-1421. 李颖萌, 范雪梅, 王义明, 等. 葛根芩连汤对2型糖尿病大鼠的治疗作用及其机制探讨[J]. 药学学报, 2013, 48(9):1415-1421.
[15] PAN J Q, XIAO L Y, HAN C, et al. Effects of Gegenqinlian Decoction on antagonizing impaired glucose tolerance in D-galactose-induced rats[J]. Guangdong Pharmaceutical Journal, 2004, 14(1):31-33. 潘竞锵, 肖柳英, 韩超, 等. 葛根芩连汤拮抗D-半乳糖诱导大鼠糖耐量减退作用[J]. 广东药学, 2004, 14(1):31-33.
[16] PAN J Q, HAN C, LIU H C, et al. Experimental study on Hypoglycemic effects of Gegenqinliantang (GGQLT)[J]. Chinese New Drugs Journal, 2000, 9(3):167-170. 潘竞锵, 韩超, 刘惠纯, 等. 葛根芩连汤降血糖作用的实验研究[J]. 中国新药杂志, 2000, 9(3):167-170.
[17] LPCI K, ALTINTOPRAK N, MULUK N B, et al. The possible mechanisms of the human microbiome in allergic diseases[J]. Eur Arch Otorhinolaryngol, 2012, 274(2):617-626.
[18] WANG Z N, KLIPFELL E, BENNETT B J, et al. Gut flora metabolism of phosphatidylcholing promotes cardiovascular disease[J]. Nat ure, 2011, 472(7341):57-63.
[19] CLEMENTE J C, URSELL L K, PARFREY L W, et al. The impact of the gut microbiota on human health:an integrative view[J]. Cell, 2012, 148(6):1258-70.
[20] CANI P D, AMAR J, IGLESIAS M A, et al. Metabolic endotoxemia initiates obesity and insulin resistance[J]. Diabetes, 2007, 56(7):1761-72.
[21] TILG H, KASER A. Gut microbiome, obesity, and metabolic dysfunction[J]. J Clin Invest, 2011, 121(6):2126-2132.
[22] CARICILLI A M, SAAD M J. Gut microbiota composition and its effects on obesity and insulin resistance[J]. Curr Opin Clin Nutr Metab Care, 2014, 17(4):312-318.
[23] FENG X G, YAN Y Z, ZENG Y P, et al. The effect of Gegen Qinlian Decoction on intestinal flora in damp-heat syndrome of type 2 diabetes[J]. World Journal of Integrated Traditional and Western Medicine, 2016, 11(8):1110-1112. 冯新格, 严育忠, 曾艺鹏, 等. 葛根芩连汤对2型糖尿病湿热证肠道菌群的影响[J]. 世界中西医结合杂志, 2016, 11(8):1110-1112.
[24] ZENG Y P, FENG X G, GU C Y, et al. Effect of intestinal flora of type 2 diabetes patients with dampness-heat syndrome treated with Gegen Qinlian Decoction[J]. Hebei Medicine, 2016, 22(10):1731-1734. 曾艺鹏, 冯新格, 谷成英, 等. 葛根芩连汤治疗对2型糖尿病湿热证肠道菌群影响[J]. 河北医学, 2016, 22(10):1731-1734.
[25] XU J, LIAN F M, ZHAO L H, et al. Structural modulation of gut microbiota during alleviation of type 2 diabetes with a Chinese herbal formula[J]. ISME J, 2015, 9(3):552-562.
[26] GUO Y, ZHANG Y C, HUANG W H, et al. Dose-response effect of berberine on bile acid profile and gut microbiota in mice[J]. BMC Complement Altern Med, 2016, 16(1):394.
[27] NOH K, KANG Y, NEPAL M R, et al. Role of intestinal microbiota in baicalin-induced drug interaction and its Pharmacokinetics[J]. Molecules, 2016, 21(3):337.
[28] AKAO T. Differences in the metabolism of glycyrrhizin, glycyrrhetic acid and glycyrrhetic acid monoglucuronide by human intes tinal flora[J]. Biol Pharm Bull, 2000, 23(12):1418-1423.
[29] CHAO J, HUO T I, CHENG H Y, et al. Gallic acid ameliorated impaired giucose and lipid homeostasis in high fat diet -induced NAFLD mice[J]. PloS One, 2014, 9(2):e96969.
[30] PAN S N, CHEN A L, HAN Z H, et al. ¹H NMR-based metabonomic study on the effects of Epimedium on glucocorticoid-induced osteoporosis[J]. J Chromatogr B Analyt Technol Biomed Life Sci, 2016, 1038:118-126.
[31] ZHANG A H, SUN H, WANG Z G, et al. Metabolomics:towards understanding traditional Chinese medicine[J]. Planta Med, 2010, 76(17):2026-2035.
[32] WANG X J, SUN H, ZHANG A H, et al. Potential role of metabolomics apporoaches in the area of traditional Chinese medicine:as pillars of the bridge between Chinese and western medicine[J]. J Pharm Biomed Anal, 2011, 55(5):859-868.
[33] MAHMOUD M F, EI-NAGAR M, EI-BASSOSSY H M. Anti-inflammatory effect of atorvastatin on vascular reactivity and insulin resistance in fructose fed rats[J]. Arch Pharm Res, 2012, 35(1):155-162.
[34] ZHANG Y F, YUAN J, ZHANG Y Z, et al. LC-MS/MS analysis of Gegen Qinlian Decoction and its pharmacokinetics after oral administration to rats[J]. Biomed Chromatogr, 2015, 29(4):485-495.
[35] HAN Z H, WANG Y L, WANG S M, et al. Effects of Gegen Qinlian decoction on plasma metabonomic profile in insulin resistance rats based on¹H NMR metabonomics[J]. Journal of Guangdong Pharmaceutical University, 2015, 31(6):786-790. 韩智慧, 王亚玲, 王淑美, 等. 基于¹H NMR代谢组学方法研究葛根芩连汤对IR大鼠模型血浆代谢组的影响[J]. 广东药学院学报, 2015, 31(6):786-790.
[36] ZHANG C H, XU G L, LIU Y H, et al. Anti-diabetic activities of Gegen Qinlian Decoction in high-fat diet combined with streptozotocin-induced diabetic rats and in 3T3-L1 adipocytes[J]. Phytomedicine, 2013, 20(3/4):221-229.
[37] WANG Z L, XIAO P Y, QI T Z. Hypoglycemic effect of Gegen Qinlian Decoction on type 2 diabetes rats[J]. China Pharmacy, 2014, 25(23):2131-2133.
[38] BARHAM D, TRINDER P. An improved colour reagent for the determination of blood glucose by the oxidase system[J]. Analyst, 1972, 97(151):142-145.
[39] MATTHEWS D R, HOSKER J P, RUDENSKI A S, et al. Homeostasis model assessment:insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man[J]. Diabetologia, 1985, 28(7):412-419.
[40] LE GALL G, NOOR S O, RIDGWAY K, et al. Metabolomics of fecal extracts detects altered metabolic activity of gut microbiota in ulcerative colitis and irritable bowel syndrome[J]. J Proteome Res, 2011, 10(9):4208-4218.
[41] SHI X H, XIAO C N, WANG Y L, et al. Gallic acid intake induced alterations to systems metabolism in rats[J]. J Proteome Res, 2013, 12(2):991-1006.
[42] ZHAO Y, WU J F, LI J V, et al. Gut microbiota composition modifies fecal metabolic profiles in mice[J]. J Proteome Res, 2013, 12(6):2987-2999.
[43] MANSOR L S, MEHTA K, AKSENTIJEVIC D, et al. Increased oxidative metabolism following hypoxia in the type 2 diabetic heart, despite normal hypoxia signalling and metabolic adaptation[J]. J Physiol, 2016, 594(2):307-320.
[44] DE VADDER F, KOVATCHEVA-DATCHARY P, ZITOUN C, et al. Microbiota-Produced succinate improves glucose homeostasis via intestinal gluconeogenesis[J]. Cell Metab, 2012, 24(1):151-157.
[45] CLAYTON T A, LINDON J C, EVERETT J R, et al. An hypothesis for a mechanism underlying hepatotoxin-induced hypercreatinuria[J]. Arch Toxicol, 2003, 77(4):208-217.
[46] WATERFIELD C J, TURTON J A, SCALES M D, et al. Investigations into the effects of various hepatotoxic compounds on urinary and liver taurine levels in rats[J]. Arch Toxicol, 1993, 67(4):244-254.
[47] RIBEIRO R A, BONFLEUR M L, AMARAL A G, et al. Taurine supplementation enhances nutrient-induced insulin secretion in pancreatic mice islets[J]. Diabetes Metab Res Rev, 2009, 25(4):370-379.
[48] CHUNG S T, HSIA D S, CHACKO S K, et al. Increased gluconeogenesis in youth with newly diagnosed type 2 diabetes[J]. Diabetologia, 2015, 58(3):596-603.
[49] DOLARA P, CADERNI G, SALVADORI M, et al. Fecal levels of short-chain fatty acids and bile acids as determinants of colonic mucosal cell proliferation in humans[J]. Nutr Cancer, 2002, 42(2):186-190.
[50] ANDOH A, TSUJIKAWA T, FUJIYAMA Y. Role of dietary fiber and short -chain fatty acids in the colon[J]. Current Pharmaceutical Design, 2003, 9(4):347-358.
[51] CHEN Y, CAO Y S, LIU X H. Short chain fatty acids and intestinal microflora[J]. Jiangxi Science, 2006, 24(1):38-39. 陈燕, 曹郁生, 刘晓华. 短链脂肪酸与肠道菌群[J]. 江西科学, 2006, 24(1):38-39.
[52] WU M M, XIAO H, REN W K, et al. An NMR-based metabolomic approach to investigate the effects of supplementation with glutamic acid in piglets challenged with deoxynivalenol[J]. PLoS One, 2014, 9(12):e113687.
[53] BURRIN D G, STOLL B. Metabolic fate and function of dietary glutamate in the gut[J]. Am J Clin Nutr, 2009, 90(3):850S-856S.

基于¹H NMR的代谢组学方法研究葛根芩连汤对高果糖诱导胰岛素抵抗大鼠粪便代谢组的影响

Effects of Gegen Qinlian Decoction on the Fecal Metabonome of High Fructose-Induced Insulin Resistance Rats Studied by ¹H NMR Spectroscopy

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	肖雄杰, HU Mary, 张许, HU Jian-zhi. 电离辐射对小鼠肾脏影响的代谢组学研究[J]. 波谱学杂志, 2019, 36(2): 172-181.
[2]	唐明学, SCHMIDT Claudia. 利用核磁共振氢谱的哈勒分析获得分子序列取向参数[J]. 波谱学杂志, 2019, 36(2): 138-147.
[3]	吴金泽, 辛家祥, 付晓彬, 姚叶锋. 通过宽线固体核磁共振氢谱研究半晶高分子的相结构[J]. 波谱学杂志, 2019, 36(1): 23-33.
[4]	张聪聪, 吴俊芳, 王玉兰. 不同性别C57BL/6小鼠肠道胆汁酸组成的差异性研究[J]. 波谱学杂志, 2018, 35(3): 328-337.
[5]	赵欣, 肖雄杰, 高东莉, 张先荣. JAK/STAT通路抑制剂对C57BL/6小鼠血清代谢组影响的¹H NMR研究[J]. 波谱学杂志, 2018, 35(2): 198-203.
[6]	胡依黎, 豪富华, 王玉兰. 基于NMR的4T1荷瘤小鼠脾脏受不同给药方式影响的代谢组学研究[J]. 波谱学杂志, 2018, 35(1): 8-21.
[7]	赵红波, 柴晓飞, 王岳华, 史会兵, 张锐, 董昭苹, 韩立霞. ¹H NMR法对改性沥青中SBS含量精确测试的研究[J]. 波谱学杂志, 2017, 34(3): 323-328.
[8]	陈朴, 于燕波, 黄贱英, 李红毅, 董海胜, 陈斌. 运动员与体力劳动者代谢组学判别模型的建立[J]. 波谱学杂志, 2016, 33(3): 395-405.
[9]	郭强胜, 刘明珂, 禹珊, 沈婷婷, 宋巍, 许旭. 定量核磁共振法同时测定复合维生素B片中B1、B2、烟酰胺和泛酸钙[J]. 波谱学杂志, 2016, 33(3): 442-451.
[10]	周秋菊, 向俊锋, 唐亚林, 崔洁, 武宁宁. 纯位移核磁共振氢谱及其应用[J]. 波谱学杂志, 2016, 33(3): 502-513.
[11]	宋懿朋, 李宁, 薛海斯, 李晶, 王玉兰. 棕色脂肪组织和白色脂肪组织的代谢组学研究[J]. 波谱学杂志, 2016, 33(2): 208-223.
[12]	周宁, 杜祥博, 杨莉, 许怡, 孙博, 张琪, 戴二黑, 颜贤忠, 董方霆. 不同病程的结核病患者的血浆代谢组学研究[J]. 波谱学杂志, 2016, 33(2): 224-235.
[13]	郑津, 薛惠芸, 林彩凤, 林德洵, 陆嘉, 杨慧, 王相鹏, 邹友思. 核磁共振氢谱法鉴定油性圆珠笔文书的书写时间[J]. 波谱学杂志, 2016, 33(2): 198-207.
[14]	韩伟健, 林晓彤, 郭娜, 陈俏, 张婷婷, 许枬. 泽泻盐制前后成分转化的¹H NMR分析[J]. 波谱学杂志, 2016, 33(1): 117-124.
[15]	魏莹1,2，章文军1，薛蓉2，李晓晶2，裴奉奎2. 基于 ¹H NMR*谱的给药赭石大鼠血清代谢组学研究 [J]. 波谱学杂志, 2015, 32(4): 628-636.